HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of growth and linoleate-enhanced metastasis of a transplantable mouse mammary tumor by indomethacin.

Abstract
The influence of the cyclo-oxygenase inhibitor, indomethacin (IM), on the metastasis, development and prostaglandin E (PGE) levels of line 4526 mammary tumors grown in mice fed high fat (HF, 20%, w/w) diets containing various levels of linoleic acid (18:2) was investigated. Control mice that grew primary tumors and were fed HF diets containing 12% 18:2 (w/w) had 2-3 times the number of lung metastases than mice fed 1%, 4%, or 8% 18:2. Chronic treatment of mice with 10 micrograms/ml IM in drinking water reduced metastasis in 1% and 4% 18:2-fed mice compared to controls and completely inhibited the increased metastasis of mice fed the 12% 18:2 diet. Treatment with IM also increased the latency and decreased the growth rates of primary 4526 tumors of all dietary groups. Treatment of mice with a higher dosage of IM (20 micrograms/ml), decreased tumor metastasis even further compared to controls, but did not decrease tumor growth rate compared to the lower dosage of IM (10 micrograms/ml). Tumor PGE levels, measured by radioimmunoassay (RIA), were decreased by IM treatment. These data provide evidence that arachidonic acid metabolites such as PGE may be involved in the metastasis of 4526 mammary tumors.
AuthorsN E Hubbard, R S Chapkin, K L Erickson
JournalCancer letters (Cancer Lett) Vol. 43 Issue 1-2 Pg. 111-20 (Dec 01 1988) ISSN: 0304-3835 [Print] Ireland
PMID3203321 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Linoleic Acids
  • Prostaglandins E
  • Linoleic Acid
  • Indomethacin
Topics
  • Animals
  • Drug Interactions
  • Female
  • Indomethacin (pharmacology)
  • Linoleic Acid
  • Linoleic Acids (pharmacology)
  • Mammary Neoplasms, Experimental (pathology)
  • Mice
  • Mice, Inbred BALB C
  • Neoplasm Metastasis
  • Neoplasm Transplantation
  • Prostaglandins E (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: